Steve Wise

Co-Head of Americas Private Equity at Carlyle

Interviewee

Stephen H. Wise is a Partner and Co-Head of Americas Corporate Private Equity at Carlyle. He is based in New York.

Previously, he was the Global Head of Healthcare at Carlyle, where he led nearly $20 billion of equity investments in healthcare companies worldwide. Since joining Carlyle in 2006, Mr. Wise has played a pivotal role in several notable investments, including CorroHealth, a business service provider for healthcare companies; Curia, a contract research and drug manufacturing organization; Medline, a leading global branded medical products manufacturer with a wholly-owned vertically integrated distribution network; MedRisk, a physical therapy-focused workers’ compensation solutions company; Millicent Pharma, a pharmaceutical company; MultiPlan, a scaled independent preferred provider organization; QuidelOrtho, a global provider of in vitro diagnostic solutions for screening, diagnosing, monitoring, and confirming diseases; Pharmaceutical Product Development (PPD), a global contract research organization; Rede D’Or São Luiz, a hospital provider in Brazil; Resonetics, a leading contract development and manufacturing organization specializing in complex micro-manufacturing of components for medical device original equipment manufacturers; Sedgwick, a global multiline claims management firm; TriNetX, a global health research network optimizing clinical research; Unchained Labs, a global life science tools company; and WellDyneRx, an independent pharmacy benefit manager. Mr. Wise also led Carlyle’s broader life sciences efforts, including the acquisition of Abingworth. His expertise and strategic vision have been instrumental in driving Carlyle’s success and growth in these sectors.

Prior to joining Carlyle, Mr. Wise worked with JLL Partners, a New York-based private equity firm, where he focused on health care-related investments. Previously, he worked with J.W. Childs Associates, a Boston-based private equity firm, and prior to that, in the leveraged finance group of Credit Suisse.

Mr. Wise serves as a director on the boards of Curia, Launch Therapeutics, Medline, and Resonetics. Mr. Wise also serves on the advisory board for the Massachusetts General Hospital Center for Global Health.

Mr. Wise earned a bachelor’s degree in economics and finance from Bucknell University and received his master’s in business administration from Harvard Business School.